These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8216549)

  • 21. Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: a study with positron emission tomography and 18F-2-fluoro-2-deoxyglucose.
    Volkow ND; Gillespie H; Mullani N; Tancredi L; Grant C; Ivanovic M; Hollister L
    Psychiatry Res; 1991 May; 40(1):69-78. PubMed ID: 1658842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia.
    Bartlett EJ; Barouche F; Brodie JD; Wolkin A; Angrist B; Rotrosen J; Wolf AP
    Psychiatry Res; 1991 May; 40(1):11-20. PubMed ID: 1946838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral glucose metabolism in type I alpha-N-acetylgalactosaminidase deficiency: an infantile neuroaxonal dystrophy.
    Rudolf J; Grond M; Schindler D; Heiss WD; Desnick RJ
    J Child Neurol; 1999 Aug; 14(8):543-7. PubMed ID: 10456768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
    Tune L; Brandt J; Frost JJ; Harris G; Mayberg H; Steele C; Burns A; Sapp J; Folstein MF; Wagner HN
    Acta Psychiatr Scand Suppl; 1991; 366():61-5. PubMed ID: 1897377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
    Chaiken L; Rege S; Hoh C; Choi Y; Jabour B; Juillard G; Hawkins R; Parker R
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):455-64. PubMed ID: 8407422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in cerebral blood flow and glucose utilization in vegetative versus locked-in patients.
    Levy DE; Sidtis JJ; Rottenberg DA; Jarden JO; Strother SC; Dhawan V; Ginos JZ; Tramo MJ; Evans AC; Plum F
    Ann Neurol; 1987 Dec; 22(6):673-82. PubMed ID: 3501694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease.
    Ogawa T; Inugami A; Fujita H; Hatazawa J; Shimosegawa E; Kanno I; Okudera T; Uemura K; Nagata K
    AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):978-81. PubMed ID: 7611090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron emission tomography in partial epilepsy and its relation to clinical and EEG findings.
    Hosokawa S; Kato M; Goto I; Ayabe Z; Kuwabara Y; Ichiya Y
    Jpn J Psychiatry Neurol; 1988 Sep; 42(3):616-7. PubMed ID: 3149381
    [No Abstract]   [Full Text] [Related]  

  • 31. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography-guided stereotactic brain biopsy.
    Levivier M; Goldman S; Bidaut LM; Luxen A; Stanus E; Przedborski S; Balériaux D; Hildebrand J; Brotchi J
    Neurosurgery; 1992 Oct; 31(4):792-7; discussion 797. PubMed ID: 1407471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of positron emission tomography in the diagnosis and monitoring of late infantile and juvenile lipopigment storage disorders (so-called Batten or neuronal ceroid lipofuscinoses).
    Philippart M; da Silva E; Chugani HT
    Neuropediatrics; 1997 Feb; 28(1):74-6. PubMed ID: 9151330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome.
    Iinuma K; Yanai K; Yanagisawa T; Fueki N; Tada K; Ito M; Matsuzawa T; Ido T
    Pediatr Neurol; 1987; 3(1):12-8. PubMed ID: 3149469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
    DeLaPaz RL; Patronas NJ; Brooks RA; Smith BH; Kornblith PL; Milam H; Di Chiro G
    AJNR Am J Neuroradiol; 1983; 4(3):826-9. PubMed ID: 6308993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [18F]-fluorodeoxyglucose-positron emission tomography findings in protein infants with severe periventricular leukomalacia and hypsarrhythmia.
    Higuchi Y; Maihara T; Hattori H; Furusho K; Okazawa H; Ishizu K; Yonekura Y
    Eur J Pediatr; 1997 Mar; 156(3):236-8. PubMed ID: 9083768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional cerebral glucose metabolism in major depressive disorder.
    Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
    Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlations of glucose metabolism and structural damage to language function in aphasia.
    Metter EJ; Riege WH; Hanson WR; Camras LR; Phelps ME; Kuhl DE
    Brain Lang; 1984 Mar; 21(2):187-207. PubMed ID: 6200176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.